Clinerion and Semicrol will cooperate on clinical trial management

| By | Clinical Trials
0
53

Clinerion and Semicrol announce a collaboration which will integrate the functionality of Clinerion’s Patient Network Explorer with Semicrol’s Fundanet CTMS. The partnership will integrate patient data throughout the clinical trial process, from planning to reporting of results.

The technical and commercial collaboration between the two companies will integrate the functionality of Clinerion’s Patient Network Explorer with Semicrol’s Fundanet Clinical Trials Management System (CTMS), enabling the automated, efficient sharing of patient data from a hospital’s electronic health records system to the CTMS running a clinical trial at that hospital.

The collaboration will give clinical trial sponsors and managers unified tools to manage trial data and workflows throughout the clinical trial process, from planning to reporting of results. This will enable a broader approach in clinical trials, drug development support and better outcomes for patients. Patient data privacy is preserved, and patient data remains within the hospital IT infrastructure throughout.

Fundanet CTMS is a world-class clinical trial management system designed to provide quick and easy access to study or subject information utilizing simple and intuitive navigation. Patient Network Explorer aggregates patient insights from anonymized patient records throughout Clinerion’s global network of partner hospitals to provide services for clinical trial protocol feasibility, site selection, and patient search and identification, as well as generating real-world data for medical access applications.

Clinerion (Basel, Switzerland) accelerates clinical research and medical access to treatments for patients. Clinerion’s Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site feasibility evaluation and real-time patient search and identification to match patients to treatments. Its technology solution provides real-world evidence analytics for medical access.

Semicrol (Santander, Spain), the creator of Fundanet CTMS, is a leader in cloud-based software solutions for the clinical research industry and is dedicated to solving problems and providing systems that make the research process more efficient and more profitable throughout the software framework.

SOURCE: clinerion
SHARE
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.